Literature DB >> 7650126

Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome.

R S Morris1, R J Paulson, M V Sauer, R A Lobo.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a serious complication of gonadotrophin usage but it is difficult to accurately predict its occurrence. Previous investigators have identified the combination of high oestradiol concentrations and oocyte number as being predictive in 80% of cases. In this study we sought to identify the incidence of severe OHSS in patients with high oestradiol concentrations and large numbers of oocytes and to evaluate the importance of pregnancy in the development of OHSS. Between 1990 and 1993, we studied 139 cycles using two assisted reproductive techniques [oocyte donor, n = 72; in-vitro fertilization (IVF), n = 67] in which either oestradiol (> 4000 pg/ml), oocyte number (> 25), or both were elevated. OHSS was diagnosed by standard criteria. There were no cases of severe OHSS in the oocyte donor group and six in the IVF group. Among 10 patients with oestradiol concentration > 6000 pg/ml and > 30 oocytes, only one had OHSS (10%). The relative risk of OHSS with pregnancy was 12 (confidence interval 2.18-66.14). We conclude that the risk of OHSS even at high levels of stimulation is lower than previously believed. Secondly, donors have a very low risk of OHSS, probably because of the absence of pregnancy. As such, cryopreservation of all oocytes in IVF cycles is a reasonable alternative to cycle cancellation or use of adjunctive medication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650126     DOI: 10.1093/oxfordjournals.humrep.a136044

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.

Authors:  Theoni B Tarlatzi; Christos A Venetis; Fabienne Devreker; Yvon Englert; Anne Delbaere
Journal:  J Assist Reprod Genet       Date:  2017-07-14       Impact factor: 3.412

2.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

3.  Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF).

Authors:  D J Hendriks; E R Klinkert; L F J M M Bancsi; C W N Looman; J D F Habbema; E R te Velde; F J Broekmans
Journal:  J Assist Reprod Genet       Date:  2004-03       Impact factor: 3.412

4.  Prediction of ovarian hyperstimulation syndrome in coasted patients in an IVF/ICSI program.

Authors:  Fatimah Y Aljawoan; Linda P Hunt; Uma D Gordon
Journal:  J Hum Reprod Sci       Date:  2012-01

5.  Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study.

Authors:  George T Lainas; Efstratios M Kolibianakis; Ioannis A Sfontouris; Ioannis Z Zorzovilis; George K Petsas; Theoni B Tarlatzi; Basil C Tarlatzis; Trifon G Lainas
Journal:  Reprod Biol Endocrinol       Date:  2012-08-31       Impact factor: 5.211

6.  A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with hCG.

Authors:  G T Lainas; T G Lainas; I A Sfontouris; C A Venetis; M A Kyprianou; G K Petsas; B C Tarlatzis; E M Kolibianakis
Journal:  Hum Reprod Open       Date:  2020-06-06

7.  The effect of early coasting on blastocyst development and outcome following blastocyst transfer in IVF/ICSI programme.

Authors:  Chandra Kailasam; Heather Griffith; Paul Wilson; Uma Gordon
Journal:  JBRA Assist Reprod       Date:  2018-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.